The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Merrill Lynch Cuts Schroders To Underperform

Tue, 07th Oct 2014 08:35

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
JPMORGAN RAISES PRICE TARGET IAG TO 5.50 (5.35) EUR - 'OVERWEIGHT'
----------
TRADERS: JPMORGAN CUTS EASYJET PRICE TARGET TO 1,815 (1,909) PENCE - 'OVERWEIGHT'
----------
TRADERS: SOCGEN RAISES ANTOFAGASTA TO 'HOLD' ('SELL')
----------
NOMURA RAISES ANTOFAGASTA TO 'NEUTRAL' ('REDUCE') - TARGET 700 (720) PENCE
----------
TRADERS: SOCGEN RAISES SMITH & NEPHEW TO 'HOLD' ('SELL')
----------
TRADERS: MERRILL LYNCH CUTS SCHRODERS TO 'UNDERPERFORM' ('BUY')
----------
TRADERS: MERRILL LYNCH CUTS SCHRODERS PRICE TARGET TO 2,400 (2,800) PENCE
----------
TRADERS: MERRILL LYNCH ADDS TRAVIS PERKINS TO 'EUROPE 1 LIST' - 'BUY'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4100 (4000) PENCE - 'HOLD'
----------
PANMURE RAISES ASTRAZENECA TO 'BUY' ('HOLD') - TARGET 4,700 (4,400) PENCE
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1420 (1450) PENCE - 'HOLD'
----------
Cantor Fitzgerald Cuts BAE Systems To Hold From Buy, Retains 460p Price Target
----------
UBS Initiates Dixons Carphone With Buy Rating, Price Target 415p
----------
EXANE BNP RESUMES EXPERIAN WITH 'NEUTRAL' - TARGET 1,050 PENCE
----------
FTSE 250
----------
DEUTSCHE BANK RAISES BTG PRICE TARGET TO 745 (655) PENCE - 'BUY'
----------
TRADERS: LIBERUM CUTS HUNTING TO 'SELL' ('HOLD')
----------
TRADERS: CANACCORD RAISES KAZAKHMYS PRICE TARGET TO 280 (272) PENCE
----------
MAIN MARKET AND AIM
----------
TRADERS: PEEL HUNT CUTS MANAGEMENT CONSULTING TO 'HOLD' ('BUY')
----------
LIBERUM CUTS IBEX PRICE TARGET TO 135 (175) PENCE - 'HOLD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.